Mesa Laboratories (NASDAQ:MLAB – Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, February 4th. Analysts expect Mesa Laboratories to post earnings of $1.41 per share and revenue of $58.83 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $1.81 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.14). The company had revenue of $57.83 million during the quarter, compared to analysts’ expectations of $58.60 million. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%. On average, analysts expect Mesa Laboratories to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Mesa Laboratories Price Performance
NASDAQ MLAB opened at $137.69 on Friday. Mesa Laboratories has a 1 year low of $83.68 and a 1 year high of $149.50. The stock’s 50-day moving average price is $132.44 and its two-hundred day moving average price is $125.09. The company has a market cap of $747.66 million, a PE ratio of -3.02 and a beta of 0.82. The company has a current ratio of 0.70, a quick ratio of 0.51 and a debt-to-equity ratio of 0.65.
Mesa Laboratories Announces Dividend
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.
Get Our Latest Analysis on Mesa Laboratories
Mesa Laboratories Company Profile
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Featured Stories
- Five stocks we like better than Mesa Laboratories
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- High Flyers: 3 Natural Gas Stocks for March 2022
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.